Beyrath, Julien David,Smeitink, Johannes Albertus Maria
申请号：
AU2017408066
公开号：
AU2017408066A1
申请日:
2017.09.05
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
The current invention concerns an innovative treatment for mitochondrial disorders and diseases or conditions associated with mitochondrial dysfunction. In particular, effective and safe dosages of compounds suitable for the treatment of mitochondrial disorders have been established, providing for new treatment regimens and patient populations.
